Mednax will change its name to Pediatrix Medical Group effective July 1, 2022. Mednax common stock will continue to trade on the NYSE under its current ticker symbol MD.

MEDNAX's GAAP loss for 3 months of 2022 was $21.192 million, compared to a profit of $17.634 million in the previous year. Revenue increased 7.9% to $482.229 million from $446.753 million a year earlier.

MEDNAX's GAAP net income for 2021 was $130.937 million, compared to a loss of $796.488 million in the previous year. Revenue increased 10.2% to $1.911 billion from $1.734 billion a year earlier.

MEDNAX reported a GAAP net profit of $83.427 million for 9M 2021, compared to a loss of $732.192 million in the previous year. Revenues increased by 7.3% to $1.413 billion from $1.317 billion a year earlier.